|
Canada-0- ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- ALS News: Breakthrough Drug Shows Promising Results In . . . - GlobalRPH
In April 2024, a patient received the first-ever antisense oligonucleotide (ASO) treatment targeting CHCHD10 mutations in amyotrophic lateral sclerosis, resulting in a reduction of disease progression by more than half
- ALS News Today Home | ALS News Today
New eye imaging approach may help distinguish ALS from Alzheimer’s An analysis of how polarized light interacts with clumps of proteins in the eyes may help differentiate amyotrophic lateral sclerosis (ALS) from Alzheimer’s disease and related conditions, a new study shows
- New ALS drug stabilizes decline with improved strength, mobility for . . .
Long-term use of tofersen, a new drug approved by the FDA for this rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some, according to a study by WashU Medicine researchers and their collaborators
- New Advancements in ALS Care: Treatments, Therapies, and Ongoing . . .
ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope See how advances at University of Utah Health are shaping the future of ALS care
- ALS News | ALS Therapy Development Institute
From trial readouts to news from our lab, you can find all of the latest ALS research news here
- Amyotrophic Lateral Sclerosis News -- ScienceDaily
Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments
- Experimental treatments brings hope to ALS patients - CBS News
Experimental treatments brings hope to ALS patients "CBS Saturday Morning" looks at an experimental treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, that is bringing hope to
- AI finds existing drugs that may extend survival for ALS patients
AI finds existing drugs that may extend survival for ALS patients Using artificial intelligence and a new trove of veteran health records, researchers have uncovered three types of drugs with
- Clinical Research Trials Update, March 2026 - ALS Society of Canada
Our bimonthly Clinical Research Trials Update keeps you up to date on what’s happening in ALS clinical research We unpack trial press releases, flag upcoming studies, and highlight important new publications, including care guidelines, long-term therapy data, and off label treatment insights We have developed a Research Glossary that contains a list of scientific and medical terms and
|
|